Bate Aaron B, Kalin Jay H, Fooksman Eric M, Amorose Erica L, Price Cristofer M, Williams Heather M, Rodig Michael J, Mitchell Miguel O, Cho Sang Hyun, Wang Yuehong, Franzblau Scott G
Department of Chemistry, Salisbury University, Salisbury, MD 21801, USA.
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1346-8. doi: 10.1016/j.bmcl.2006.11.091. Epub 2006 Dec 2.
Quaternized chlorpromazine, triflupromazine, and promethazine derivatives were synthesized and examined as antitubercular agents against both actively growing and non-replicating Mycobacterium tuberculosis H37Rv. Impressively, several compounds inhibited non-replicating M. tuberculosis at concentrations equal to or double their MICs against the actively growing strain. All active compounds were non-toxic toward Vero cells (IC50 > 128 microM). N-Allylchlorpromazinium bromide was only weakly antitubercular, but replacing allyl with benzyl or substituted benzyl improved potency. An electron-withdrawing substituent on the phenothiazine ring was also essential. Branching at the carbon chain decreased antitubercular activity. The optimum antitubercular structures possessed N-(4- or 3-chlorobenzyl) substitution on triflupromazine.
合成了季铵化氯丙嗪、三氟丙嗪和异丙嗪衍生物,并作为抗结核药物对活跃生长和非复制状态的结核分枝杆菌H37Rv进行了检测。令人印象深刻的是,几种化合物对非复制状态的结核分枝杆菌的抑制浓度等于或两倍于其对活跃生长菌株的最低抑菌浓度(MIC)。所有活性化合物对Vero细胞均无毒(半数抑制浓度IC50>128微摩尔)。N-烯丙基氯丙嗪溴化物的抗结核活性较弱,但用苄基或取代苄基取代烯丙基可提高效力。吩噻嗪环上的吸电子取代基也是必不可少的。碳链上的支链会降低抗结核活性。最佳的抗结核结构是三氟丙嗪上具有N-(4-或3-氯苄基)取代。